Tradestie Institutional Equity Comparison Engine
SVRA vs DSGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SVRA Overall Edge
SVRA Captures Institutional Edge (2โ2 Pillars ยท 4โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Savara Inc. (SVRA) driven by superior Valuation, Options & Structure while DSGN counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, SVRA trades at 0.4x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus DSGN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SVRA sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against DSGN sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
SVRA
SVRA 0.4x vs DSGN N/M Fwd P/E
Growth & Margin Winner
DSGN
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
DSGN
1Y +3.9% vs +40.8% ยท 52W Pos 13% vs 30%
Options & Structure Winner
SVRA
BREAKDOWN (17th %ile IV) vs BREAKDOWN (13th %ile IV)
SVRA
NASDAQ
Savara Inc.
Pharmaceutical Preparations
$4.42
-4.63% 1D
Market Cap
$1.1B
1M Return
-0.56%
1Y Return
+3.87%
Forward P/E
0.4x
Unified AI Score
55.6 / 100
HOLD
Tech 30.0
Fund 54.0
Flow 70.0
Mom 54.0
DSGN
NASDAQ
Design Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$9.94
-5.06% 1D
Market Cap
$677.5M
1M Return
-3.59%
1Y Return
+40.79%
Forward P/E
N/M
Unified AI Score
49.8 / 100
HOLD
Tech 55.0
Fund 57.0
Flow 63.0
Mom 54.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SVRA +3.87%
DSGN +40.79%
Spread: +36.92 pp (DSGN Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SVRA Revenue | DSGN Revenue | SVRA Op. Margin | DSGN Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2010 | $0M | N/A | -1746.5% | N/A | SVRA |
| FY2015 | $0M | N/A | -10968.5% | N/A | SVRA |
| FY2016 | $0M | N/A | -2737.0% | N/A | SVRA |
| FY2020 | $0M | $0M | -19182.9% | -3685.8% | DSGN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SVRA | DSGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.1B | $677.5M | Larger Scale | SVRA |
| Trailing P/E Ratio Valuation | 0.4x | N/M | Lower Multiple | SVRA |
| Forward P/E Ratio Valuation | 0.4x | N/M | Lower Multiple | SVRA |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -151.0% | -36.9% | Higher ROE | DSGN |
| 52-Week Range Position Momentum | 13% ($4โ$7) | 30% ($7โ$17) | Stronger Trend | DSGN |
| Beta / 30D Volatility Risk Regime | 1.48ฮฒ ยท 73% Vol | 1.32ฮฒ ยท 61% Vol | Lower Realized Risk | DSGN |
| Unified Institutional Score Composite Signal | 55.6 / 100 (HOLD) | 49.8 / 100 (HOLD) | Higher Composite | SVRA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SVRA vs DSGN Buy Guide
SVRA
BREAKDOWN
92d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
17th %ile
IV Regime
Compressed (<25th %ile)
DSGN
BREAKDOWN
139d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
13th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SVRA nor DSGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.